If GMP already accommodates AI, the next challenge is practical execution. The goal is not to “add AI compliance,” but to embed AI into existing quality systems with intent and discipline. Part 2 of this series (here) unconsciously introduced the often-misunderstood concept of “critical thinking,” which is easy to say, but difficult to perform in practice.

Part 1 and Part 2 Self Reflection:

“Are we using our QMS/PQS to enable AI, or are we working around it?”

If the latter is true, now is the moment to recalibrate. A unified, GMP-aligned AI-governance framework will enable scalability, credibility, and inspection readiness – the exact outcomes this series set out to help you achieve.

Below is a highly abbreviated road map to consider; however, the devil lies in the details.

1. Define the Context of Use (COU)

This remains the single most important step, shaping validation depth, monitoring frequency, and governance controls.

2. Apply Computerized System Controls Already Required by GMP

The principles of Part 11, Annex 11, data integrity, cybersecurity, and access management all apply directly, complemented by controls that ensure AI is governed consistently across its full lifecycle.

3. Implement Lifecycle Management

AI models drift, evolve, and require ongoing verification, much like processes do.

4. Establish Cross-Functional Governance

AI cannot live within IT or data science alone. GMP demands qualified personnel, shared accountability, and documented decision making.

5. Harmonize Across Regions

Regulatory convergence (here) makes unified global governance not only possible but strategically advantageous.

AI should fall cleanly under existing computerized system controls. Part 11, Annex 11, data integrity, cybersecurity, and access management are not optional considerations—they are the backbone that allows AI to be trusted in regulated environments.

Lifecycle thinking is equally critical. AI systems are designed to evolve. Data changes, performance drifts, and assumptions age. Continuous monitoring and periodic reassessment, already expected for processes and methods, must extend to AI models as well.

Equally important is organizational design. AI governance cannot reside solely with data scientists or IT. GMP requires qualified personnel and defined accountability, which naturally supports multidisciplinary oversight spanning quality, regulatory, IT, and business leadership.

Finally, global alignment matters. The FDA–EMA convergence provides an opportunity to harmonize governance rather than replicate it regionally. A single, well-designed framework, grounded in GMP principles, can serve both regulatory landscapes.

Thought Leadership Takeaway

The limiting factor for AI adoption will not be regulation—it will be organizational readiness, trust, and governance maturity. History shows that technology outpaces comfort long before it outpaces rules.

Call to Action

Find a trusted advisor to help facilitate your organization’s “readiness for change.” In-house SMEs are powerful change agents, and enlightened leaders are critical; however, organizations, just like people, can have inherent bias. Utilizing an independent entity, such as Lachman, can give an unprecedented pan-industry view.